Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Diseases of the Thyroid

  Free Subscription


Articles published in Clin Cancer Res

Retrieve available abstracts of 20 articles:
HTML format

Single Articles


    June 2008
  1. PRASAD NB , Somervell H, Tufano RP, Dackiw AP, et al
    Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors.
    Clin Cancer Res. 2008;14:3327-3337.
    PubMed     Related articles    Abstract available


    March 2008
  2. LIN SF , Gao SP, Price DL, Li S, et al
    Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer.
    Clin Cancer Res. 2008;14:1519-1528.
    PubMed     Related articles    Abstract available


    January 2008
  3. KLOPPER JP , Berenz A, Hays WR, Sharma V, et al
    In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma.
    Clin Cancer Res. 2008;14:589-596.
    PubMed     Related articles    Abstract available


    November 2007
  4. ITEN F , Muller B, Schindler C, Rochlitz C, et al
    Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial.
    Clin Cancer Res. 2007;13:6696-6702.
    PubMed     Related articles    Abstract available


    August 2007
  5. KONDO T , Zhu X, Asa SL, Ezzat S, et al
    The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer.
    Clin Cancer Res. 2007;13:4713-20.
    PubMed     Related articles    Abstract available


  6. GOMEZ-RIVERA F , Santillan-Gomez AA, Younes MN, Kim S, et al
    The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model.
    Clin Cancer Res. 2007;13:4519-27.
    PubMed     Related articles    Abstract available


    May 2007
  7. EKEBLAD S , Sundin A, Janson ET, Welin S, et al
    Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
    Clin Cancer Res. 2007;13:2986-91.
    PubMed     Related articles    Abstract available


    February 2007
  8. LIU D , Hu S, Hou P, Jiang D, et al
    Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
    Clin Cancer Res. 2007;13:1341-9.
    PubMed     Related articles    Abstract available


  9. HOU P , Liu D, Shan Y, Hu S, et al
    Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
    Clin Cancer Res. 2007;13:1161-70.
    PubMed     Related articles    Abstract available


    October 2006
  10. HYER ML , Samuel T, Reed JC
    The FLIP-side of Fas signaling.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles   


    September 2006
  11. LUONG QT , O'Kelly J, Braunstein GD, Hershman JM, et al
    Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
    Clin Cancer Res. 2006;12:5570-7.
    PubMed     Related articles    Abstract available


    August 2006
  12. WANG Z , Chakravarty G, Kim S, Yazici YD, et al
    Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (a12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Clin Cancer Res. 2006;12:4755-65.
    PubMed     Related articles    Abstract available   Free Full Text


    June 2006
  13. MITSIADES CS , Poulaki V, Fanourakis G, Sozopoulos E, et al
    Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
    Clin Cancer Res. 2006;12:3705-12.
    PubMed     Related articles    Abstract available


  14. MATHEW R , White E
    FLIPping the Balance between Apoptosis and Proliferation in Thyroid Cancer.
    Clin Cancer Res. 2006;12:3648-51.
    PubMed     Related articles   


  15. YOUNES MN , Yazici YD, Kim S, Jasser SA, et al
    Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer.
    Clin Cancer Res. 2006;12:3425-34.
    PubMed     Related articles    Abstract available   Free Full Text


  16. CERUTTI JM , Latini FR, Nakabashi C, Delcelo R, et al
    Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers.
    Clin Cancer Res. 2006;12:3311-3318.
    PubMed     Related articles    Abstract available   Free Full Text


    April 2006
  17. MCCARTHY RP , Wang M, Jones TD, Strate RW, et al
    Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
    Clin Cancer Res. 2006;12:2414-8.
    PubMed     Related articles    Abstract available


  18. GIORDANO TJ , Au AY, Kuick R, Thomas DG, et al
    Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation.
    Clin Cancer Res. 2006;12:1983-93.
    PubMed     Related articles    Abstract available


    March 2006
  19. OUYANG B , Knauf JA, Smith EP, Zhang L, et al
    Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo.
    Clin Cancer Res. 2006;12:1785-93.
    PubMed     Related articles    Abstract available


  20. CHILOECHES A , Marais R
    Is BRAF the Achilles' Heel of Thyroid Cancer?
    Clin Cancer Res. 2006;12:1661-4.
    PubMed     Related articles   


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: